but concentrated in specialized microdomains. Moesin phate 5-kinase in ERM activation [15] . Obviously studies expression has been visualized in the intracellular core of report variation in the most relevant pathway from RhoA microextensions known as filopodia, microvilli and retracto ERM activation. Both stabilising and destabilising tion fibers. The distribution pattern follows closely the proteins are downstream of RhoA activation, which is dynamic changes in cell shape in relation to spreading and suggestive for a delicate balance between stabilising and moving of cells either spontaneously or in response to destabilising proteins competing for actin binding. In extracellular stimuli [6] . These characteristics would make addition, as suggested by Mack et al. [16] RhoA signaling moesin a likely candidate to contribute to or effectuate may function as a convergence point for the different changes in phenotype of SMC following stress.
pathways involved. Further interactions between RhoA and actin have been suggested and links between the level of RhoA activity and G-and F-actin ratios have been demonstrated [17] . In fact, actin appears to be not only the 3. SMC signalling target but also a modulator of activity of actin associated proteins such as moesin, smoothelin and tropomyosin (Fig. The signalling events involved in SMC (de)differentia-1). tion are numerous including cytokines and growth factordependent pathways. Blocking SMC dedifferentiation and thus neointima formation after PTCA in healthy animal vessels was performed successfully with platelet-derived 4. The battle for actin growth factor (PDGF) antibodies and also antisense approaches blocking the receptor. The results are indicative F-actin assembly and disassembly is the driving process of important role for this growth factor [7, 8] . In addition to behind phenotypic changes of SMC. Assembly is needed interventions in the PDGF pathway, other growth factors to provide the cells with a contractile apparatus or prepare were demonstrated to contribute, including TGF-b and them for migration and proliferation. As indicated above, IGF-1, both during angiogenesis and under pathologic several signaling molecules target actin directly or indirectcircumstances. Unfortunately, many promising approaches ly. In addition, there is cross talk between actin and the were designed for and tested in healthy animal vessels, and associated proteins. Such proteins can be specific for the the obtained results could not be (fully) reproduced in phenotype of the SMC or for the status of actin. At human atherosclerotic vessels. The only exception thus far present, a number of such marker proteins are available to is based on a total block of protein synthesis by the local monitor SMC differentiation processes (Table 1 ) [18] [19] [20] [21] . application of the immunosuppressor rapamycin, now Calponin and SM22 are specific for SMC, but their called sirolimus [9, 10] .
binding to actin is controversial. Proteins as smoothelin, For the recruitment and differentiation of SMC, but also caldesmon and tropomyosin are expressed in contractile during the dedifferentiation an important role for rho-SMC and appear to play a role in contraction, but only the GTPase and associated proteins like the rho-GDP dissociaexpression of smoothelin is limited to and therefore tion inhibitor has been suggested. RhoA activates two specific for the contractile phenotype of SMC [22, 23] . The groups of kinases protein kinase N and Rho kinases protein is not detected in any other cell type. Moesin and (ROKa and p160). Blocking rhoA or rhoA kinase p160 the other ERM proteins interact with actin in migrating interferes with the organisation of actin into stress fibers undifferentiated SMC, but these proteins are also exand coronary SMC differentiation during embryonic depressed in non-muscle cells. Proteins such as gelsolin, velopment as well as vascular remodeling during profilin, cofilin and actinin regulate the polymeric state and atherogenesis [11, 12] . The crucial role of rhoA for rat length of the actin filaments. All these proteins compete for SMC-specific gene expression was elucidated by looking a position on or near actin from which they can influence at the promotor activity of the SMC-specific promoters, actin assembly and, therefore, the SMC differentiation SM22 and SM alpha-actin. Expression of a dominant
state. An influence they exert by tilting the ratio of positive rhoA increased promoter activity, while inhibition filamentous versus globular actin, which again interferes of stress fiber formation with the rho-kinase inhibitor with signaling pathways. Understanding the complicated Y-27632 significantly decreased the activity of SM22 and interplay between actin, actin-associated proteins and SM alpha-actin promoters. The direct interaction between signaling proteins will provide new ways to approach rho-kinase activation and moesin has been demonstrated in pathological developments such as restenosis and but also COS7 cells [13] . In addition to interactions with moesin, atherosclerosis. As these processes are extremely important rho-kinase activation results in myosin light chain phosfor oncology, it seems likely that insight will be gained phorylation and LIM kinase activation [14] . LIM kinase faster in the molecular analysis of metastasis and cell can inactivate cofilin, a protein that promotes actin disdivision. The scientific interest in restenosis could be assembly. Yet another study in NIH3T3 and Hela cells markedly reduced if the drug eluting stents hold their indicates a dominant role for phosphatidyl-inositol 4-phospromise [10] . facilitates polymerization and break-down of actin. Another group (calponin etc.) stabilizes F-actin. Moesin and smoothelin belong to this group but stand apart from the other members since they specifically associate with the higher structures which the F-actin fibers are embedded in. Smoothelin and moesin can be classified as phenotype-specific. Rho-kinase is (one of) the central player in this scheme but only the most relevant relationships have been depicted.
Differentiated vs. undifferentiated SMC
lead to the identification of factors governing SMC differentiation. Although promoters of actin and associating The crucial role of RhoA in actin regulation determining proteins contain many conserved cis-elements, no common cell mobility has been established. Moesin could play an building plan has been revealed thus far. Currently, it is important role as a RhoA downstream effector. also unclear whether one transcription factor or a whole An important issue is the inflammatory response (TNFcluster of transcription regulating genes is required for a a and TGF-b) evoked by the damage to the vascular wall phenotypic change. Despite all the difficulties, improved either through the disease atherosclerosis or the treatment bioinformatics combined with promoter analysis appears to remains. After PTCA macrophages will infiltrate and hold little promise for the elucidation of processes like factors such as NF-kB will be activated [24] . NF-kB, a SMC differentiation. ubiquitous transcription factor involved in acute phase An alternative approach in search for the key players in responses, mediates changes in gene expression. This SMC (de)differentiation appears to be proteomics, gene sequence of events results in dedifferentiation, migration array or differential display analysis of growth factor and towards the lumen of the blood vessels, and finally cytokine influences on SMC [25] . proliferation of SMC. Information on the interaction Although our knowledge of interacting genes is growing between inflammation dependent activators and the other exponentially, functional studies remain the cornerstone of signaling pathways described above remains an exciting molecular studies. The suggested importance of molecules field to explore.
like moesin for SMC migration should be confirmed by One would expect that knowledge of expression patterns genetic interventions in vivo. of genes, albeit similar (moesin and tropomodulin) or mutual exclusive (smoothelin vs. moesin), could provide a route to analyse the mechanism of SMC (de)differentiation References by comparison of promoters or other regulatory elements. Identification of common enhancers or repressors could
[1] Gruntzig AR, Senning A, Siegenthaler WE. Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary Table 1 angioplasty. New Engl J Med 1979;301:61-68. Gene expression in smooth muscle cells 
